HOME › DRUGS › BRIVARACETAM
ACTIVE SUBSTANCE / INN

BRIVARACETAM

Brand name(s): BRIVIACT, Briviact (in Italy: Nubriveo), BRIVARACETAM
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA214918
ANDA214831
ACTIVE SUBSTANCE
Brivaracetam
REGULATORS
FDA · EMA
SPONSORS / MAH
LUPIN LTD, ANNORA PHARMA, UCB Pharma SA
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BRIVARACETAMANDA214880MICRO LABSPrescription
BRIVARACETAMANDA214918LUPIN LTDDiscontinued
BRIVIACTNDA205836UCB INCPrescription
BRIVARACETAMANDA214831ANNORA PHARMANone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Briviact (in Italy: Nubriveo)UCB Pharma SAAuthorised13/01/2016Epilepsy

FULL INTELLIGENCE ON BRIVARACETAM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →